USPTO 2015–2025 USPTO PatentsView US Corporation

Siluria Technologies, Inc.

USPTO PatentsView assignee record - 38 granted patents across 19 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

RSS updates for this company

The verdict

According to USPTO PatentsView, Siluria ranks #8,480 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 19 technology areas.

#8,480
of 49,997 US assignees by volume
Top 29%
by Innovation Score (43.1/100)
26.9
avg claims per patent
-94%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8480 · US Corporation #8,480 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 38 grants
  • UPPER-Q #8,480/49,997
  • PHOTO-FINISH Sapience Therapeutics
  • CPC-FOCUS C07C · 19 areas
  • INNOV-PAR 43.1/100
  • CLAIMS-DENSE 26.9 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -94% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sapience Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Siluria

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Siluria's Innovation Score is 43.1/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Siluria's grants concentrate

Siluria Technologies, Inc. is a focused PatentsView assignee: 19 CPC subclasses with 94.7% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2017 (11 grants) versus a trough of 2 in 2020. By volume, Siluria sits between Sapience Therapeutics, Inc. and Teijin Aramid B.V..

Who files at Siluria's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Siluria holds 38 patents at rank #8,482, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Siluria

By rank, the assignees closest to #8,482 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Siluria's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Siluria, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Siluria's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 201520162017201820192020 2
USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Siluria Technologies, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 7.9%
2016 10 26.3%
2017 11 28.9%
2018 5 13.2%
2019 7 18.4%
2020 2 5.3%

Which technologies does Siluria Technologies, Inc. patent most?

Top 15 of 19 technology areas

Where it ranks

Overall rank by patents

#8,480

of 49,997 tracked assignees

Innovation Score

43.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Siluria Technologies, Inc.'s patent record in context - here's where to go next.

  • Siluria Technologies, Inc.'s lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 94.7% of its portfolio - see every assignee active in that class. Explore C07C
  • Ranked #8,480 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Siluria Technologies, Inc. against Sapience Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.